CURR INFECT DIS REP 润色咨询

Current Infectious Disease Reports

出版年份：暂无数据 年文章数：567 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：0.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1207474, encodeId=7521120e474f8, content=只接受约稿或高质量综述（基本国外的综述）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a8f2283132, createdName=121cd313m76(暂无昵称), createdTime=Thu Mar 31 10:49:41 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001147, encodeId=a2a3100114e1a, content=只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7ba5480600, createdName=ms1000000597481767, createdTime=Tue Jul 20 14:08:55 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846492, encodeId=21c68464923b, content=审稿速度:4.0<br>经验分享：应该算是传染病中比较中游的期刊，不能投稿特别好的期刊就考虑这个期刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Tue Aug 21 17:22:30 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2022-03-31 121cd313m76(暂无昵称)

    只接受约稿或高质量综述（基本国外的综述）

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207474, encodeId=7521120e474f8, content=只接受约稿或高质量综述（基本国外的综述）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a8f2283132, createdName=121cd313m76(暂无昵称), createdTime=Thu Mar 31 10:49:41 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001147, encodeId=a2a3100114e1a, content=只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7ba5480600, createdName=ms1000000597481767, createdTime=Tue Jul 20 14:08:55 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846492, encodeId=21c68464923b, content=审稿速度:4.0<br>经验分享：应该算是传染病中比较中游的期刊，不能投稿特别好的期刊就考虑这个期刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Tue Aug 21 17:22:30 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2021-07-20 ms1000000597481767

    只接受约稿

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207474, encodeId=7521120e474f8, content=只接受约稿或高质量综述（基本国外的综述）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4a8f2283132, createdName=121cd313m76(暂无昵称), createdTime=Thu Mar 31 10:49:41 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001147, encodeId=a2a3100114e1a, content=只接受约稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e7ba5480600, createdName=ms1000000597481767, createdTime=Tue Jul 20 14:08:55 CST 2021, time=2021-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=846492, encodeId=21c68464923b, content=审稿速度:4.0<br>经验分享：应该算是传染病中比较中游的期刊，不能投稿特别好的期刊就考虑这个期刊吧 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=29385414100, createdName=ms9497043704145630, createdTime=Tue Aug 21 17:22:30 CST 2018, time=2018-08-21, status=1, ipAttribution=)]
    2018-08-21 ms9497043704145630

    审稿速度:4.0
    经验分享：应该算是传染病中比较中游的期刊，不能投稿特别好的期刊就考虑这个期刊吧

    0

共3条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分